Comparison of estimations of urinary bladder volume in different scanning positions using 2D linear dimension formula and 3D bladder circumference tracing in client-owned cats.

Urinary bladder volume (UBV) can be estimated using point-of-care ultrasound. The purpose of this study was to compare 2 UBV estimation methods, i.e., three-dimensional (3D) bladder circumference tracing and 2-dimensional (2D) linear bladder dimension formula, against actual bladder volumes in awake client-owned cats and identify the best scanning position for UBV estimations. Up to 3 paired sets of orthogonal longitudinal and transverse bladder ultrasound images were acquired by a trained clinician from 21 cats positioned in dorsal, right lateral, and left lateral recumbency. UBV estimation was performed with these images by 2 different observers using both methods. Actual bladder volumes were measured through urethral catheterization and compared to the estimated UBV using Lin's concordance correlation coefficient and Bland-Altman analyses. Considering all positions, both methods showed substantial strength-of-agreement with actual bladder volumes; the 3D bladder circumference method (ρc = 0.963, 95% CI: 0.952 to 0.974) with a significant median bias of -4.08 mL (P < 0.001, IQR -7.63 to -0.68 mL, LOA -48.55 to 21.75 mL) and the 2D linear dimension method (ρc = 0.974, 95% CI: 0.966 to 0.982) with a median bias of -0.82 mL (P = 0.686, IQR -3.89 to 4.05 mL, LOA -35.23 to 35.21 mL). Scanning in left lateral recumbency provided the strongest strengths-of-agreement and precision against actual bladder volumes for both methods. Regardless of scanning positions, the 2D linear dimension method is more accurate than the 3D bladder circumference method, although both methods are imprecise with increasing volumes and UBV assessment through urinary catheterization remains the gold standard.

Le volume vésical (UBV) peut être estimé à l'aide de l'échographie au point d'intervention. L'objectif de cette étude fut de comparer 2 méthodes d'estimation du UBV, i.e., le tracé tridimensionnel (3D) de la circonférence de la vessie et la formule de dimension linéaire en 2 dimensions (2D), aux volumes vésicaux réels chez des chats éveillés appartenant à des clients, ainsi que d'identifier la meilleure position de balayage pour l'estimation du UBV. Jusqu'à 3 séries appariées d'images ultrasonores longitudinales et transverses orthogonales ont été acquises par une clinicienne qualifiée sur 21 chats positionnés en décubitus dorsal, latéral droit et latéral gauche. L'estimation du UBV a été réalisée à partir de ces images par 2 observateurs différents utilisant les 2 méthodes. Les volumes vésicaux réels ont été mesurés par cathétérisme urétral et comparés aux UBV estimés à l'aide du coefficient de corrélation de concordance de Lin et d'analyses de Bland-Altman. Toutes positions confondues, les 2 méthodes ont montré une concordance considérable avec les volumes vésicaux réels; la méthode de la circonférence vésicale 3D (ρc = 0,963, 95 % CI : 0,952 à 0,974) avec un biais médian significatif de −4,08 mL (P < 0,001, IQR −7,63 à −0,68 mL, LOA −48,55 à 21,75 mL) et la méthode de la dimension linéaire 2D (ρc = 0,974, 95 % CI : 0,966 à 0,982) avec un biais médian de −0,82 mL (P = 0,686, IQR −3,89 à 4,05 mL, LOA −35,23 à 35,21 mL). Le balayage en décubitus latéral gauche a démontré les meilleures concordance et précision par rapport aux volumes vésicaux réels pour les 2 méthodes. Quelle que soit la position de balayage, la méthode de la dimension linéaire 2D est plus précise que la méthode de circonférence vésicale 3D, bien que les 2 méthodes deviennent imprécises avec des volumes vésicaux plus élevés et que l'évaluation du UBV par cathétérisme urinaire demeure l'étalon d'or.(Traduit par les auteurs).

Primary repair of nonsteroidal anti-inflammatory drug-associated full thickness gastrointestinal ulcers in 11 dogs.

OBJECTIVE: To report the outcomes of dogs that underwent primary repair of gastroduodenal perforations associated with the administration of nonsteroidal anti-inflammatory drugs (NSAID). A secondary objective was to identify clinicopathological findings that predisposed dogs to postoperative death. STUDY DESIGN: Retrospective study. ANIMALS: Eleven dogs with complete gastric or duodenal perforation related to administration of an NSAID that underwent primary surgical repair. METHODS: Medical records were reviewed for dogs that presented with peritonitis due to a complete gastroduodenal perforation while receiving NSAIDs between November, 2011 and January, 2021. Data collected included patient characteristics, clinical signs, clinicopathological results, surgical details, and postoperative management and outcome. RESULTS: All dogs were large breeds (mean weight 42 kg; range 22-75 kg), with a mean age of 7.35 years. Nine dogs from a total of 11 (82 %) received a concurrent corticosteroid and NSAID, or a higher dose/frequency/length of NSAID administration than recommended by the manufacturer. All gastroduodenal perforations were found in the upper gastrointestinal tract. Eight of 11 (73%) dogs survived to discharge. The median postoperative duration of follow up was 444 days (range 2-1460 days). No association was detected between ulcer size or location and mortality. CONCLUSION: Most dogs who underwent primary repair of complete gastroduodenal ulcers survived. Gastroduodenal perforations were generally due to the administration of higher or longer doses of NSAIDs, or concurrent administration of another NSAID or corticosteroid. CLINICAL SIGNIFICANCE: Primary closure may be associated with a high success rate in dogs with full thickness gastroduodenal ulcers.